United States · Funded startup

Who invested in Sonoma Biotherapeutics

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 12 months ago

Funding summaryUpdated 26 Oct 2026

$300Kraised across 1 round since 2025, from 1 source

Latest round
Grant, $300KNov 2025
Investors
5
See who backed them

The rounds

  1. Nov 2025

Founders and team

From the SEC filings it signed: 1 on the team.

  • Jeffrey BluestoneExecutive Officer, Director, Promoteri

On the board, as filediFan YuMaggie WilderotterRichard KlausnerTerry RosenToni Hoover

Everyone who backed them

8VCVC firm1round
FidelityVC firm1round
Janus Henderson InvestorsPrivate equity1round
Lilly Asia VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Sonoma Biotherapeutics

Who invested in Sonoma Biotherapeutics?

Sonoma Biotherapeutics's investors include 8VC, Fidelity, ARCH Venture Partners, Janus Henderson Investors and Lilly Asia Ventures.

How much has Sonoma Biotherapeutics raised?

Sonoma Biotherapeutics has raised $300K across 1 round since 2025.

When did Sonoma Biotherapeutics last raise?

Sonoma Biotherapeutics's most recent round was a Grant of $300K in Nov 2025.

What was Sonoma Biotherapeutics's biggest round?

Its most recent round, $300K in Nov 2025, is also its largest on record.

Who backed Sonoma Biotherapeutics first?

Sonoma Biotherapeutics's first round on record, in Nov 2025, was backed by 8VC, Fidelity and ARCH Venture Partners and 2 others.

What stage is Sonoma Biotherapeutics at?

Sonoma Biotherapeutics's latest named round is a Grant, in Nov 2025.

Where is Sonoma Biotherapeutics based?

Sonoma Biotherapeutics is based in the United States.

Companies like Sonoma Biotherapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.